Kalaris Therapeutics (KLRS) Payables (2019 - 2026)
Kalaris Therapeutics' Payables was $1.12 million in Q2 2026, down 69.5% from $3.68 million a year earlier but up 24.2% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, Payables at Kalaris Therapeutics came in at $1.28 million, down 93.9% from FY2024.
- Payables shows a five-year compound annual growth rate of 5.9% (FY2020 to FY2025).
- In earlier years, Payables was $21.1 million in FY2024 (+212.1%), $6.76 million in FY2023 (+125.1%), $3 million in FY2022 (-64.1%) and $8.36 million in FY2021 (+768.2%).
- Quarterly Payables has moved between $51,000 (Q3 2024) and $21.1 million (Q4 2024) over five years.
- Compared with a year earlier, Payables has declined for three straight quarters, with growth averaging 138.2% over the last seven quarters.
- The best year-over-year quarter for Payables over five years was Q3 2025 (growth of 868.6%); the worst was Q3 2024 (a decline of 98.7%).
- Per Business Quant data, KLRS's Payables in the three quarters before Q2 2026 was $905,000 (Q1 2026), $1.28 million (Q4 2025) and $494,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Kalaris Therapeutics | 67.84 Mn | 67.84 Mn | - | 1.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 905,000.00 |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 494,000.00 |
| Jun 30, 2025 | 3.68 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 21.10 Mn |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 110,000.00 |
| Mar 31, 2024 | 765,000.00 |
| Dec 31, 2023 | 6.76 Mn |
| Sep 30, 2023 | 3.93 Mn |
| Jun 30, 2023 | 5.16 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 4.89 Mn |
| Jun 30, 2022 | 5.52 Mn |
| Mar 31, 2022 | 4.47 Mn |
| Dec 31, 2021 | 8.36 Mn |
| Sep 30, 2021 | 133,000.00 |
API Access
Kalaris Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();